Coherent Market Insights published a business research report on Human Reproductive Technologies Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2022–2028. Human Reproductive Technologies Market with 150+ market data Tables, Pie Chat, Graphs & Figures spread through Pages and easy to understand detailed analysis. The information is gathered based on modern floats and requests identified with the administrations and items.
The global Human Reproductive Technologies Market analysis further provides pioneering landscape of market along with market augmentation history and key development involved in the industry. The report also features comprehensive research study for high growth potential industries professional survey with market analysis. Human Reproductive Technologies Market report helps the companies to understand the market trends and future market prospective,opportunities and articulate the critical business strategies.
Get Sample Report with Latest Covid19 Impact Analysis @ https://www.coherentmarketinsights.com/insight/request-sample/3921
Human reproductive technologies count homosexual reproduction, contraception, pathology, and assisted reproductive technologies (ART). ART assists in the therapy of hormone therapy, fertility drugs, cytoplasmic transfer, cloning, artificial insemination infertility or infertility using artificial insemination, and others.
Global Human Reproductive Technologies Market: Drivers
Rising maternal mortality rates are likely to increase the global human reproductive technologies market in the estimated period. For example, by maternal mortality: From 1990 to 2015, the United Nations Department of Population, World Bank Group, UNFPA, UNICEF and WHO, sub-Saharan Africa noted the highest maternal mortality rate of 555 per 100,000 live births. 1990 to 2015. Furthermore, the United Nations is focused on achieving the Sustainable Development Goals 2015-2030 targeting a global maternal mortality ratio of less than 70/100,000 live births.
Furthermore, lower birth rates are likely to help the market growth. For example, in 2018, as per the National Vital Statistics System, the temporary number of births for the U.S. was 3,788,235, down 2% from 2017 and the lowest number of births in 32 years.
In 2019, North America led the global human reproductive technologies market, considering 46.1% in value, then Europe and Asia Pacific, sequentially.
The size of the global human reproductive technologies market was estimated to be accounted at US$ 28,426.7 Million and over the estimated market (2020-2027) it is estimated to witness a value of US$ 34,228.3 Million with a CAGR of 2.4%.
Global Human Reproductive Technologies Market: Restraints
Limited insurance protection for ART is likely to obstruct the growth of the market. ART is a proportionally new and fully proven procedure in many countries. This situation makes insurance companies afraid to cover the cost. In Canada, for example, there is limited funding for IVF and intracytoplasmic sperm injections, so infertile couples have to bear the cost of therapy. The average cost of infertility therapy in Canada is very expensive, ranging from US$ 10,000 to US$ 20,000.
Furthermore, the therapy of infertility may not be convincing or efficient and therefore may need to be repeated at times. Such a risk of duplication of processes negatively affects the decision of the consumer and obstructs the growth of the market.
Global Human Reproductive Technologies Market: Opportunities
The rising literacy rate is likely to provide profitable growth opportunities for players in the global human reproductive technologies market. For example, as per the United Nations Children’s Fund, during 1985-2018, the youth literacy rate has grown from 83% to 91% globally.
Furthermore, research and development in the male contraceptive pill is also likely to contribute to the growth of the market. For example, researchers at the University of Washington in March 2018 presented positive results from a small clinical trial of 100 men for a male contraceptive pill that inhibits testosterone production.
Global Human Reproductive Technologies Market: Key Takeaways
The growing population is likely to increase the demand for emergency human reproductive technologies. For example, as per the Population Reference Bureau (PRB) estimates counted in the 2018 World Population Data Sheet, by 2050 the world’s population is likely to reach 9.9 billion, an increase of 2.3 billion or 29% over the estimated 7.6 billion.
However, in emerging economies, less adoption of emergency human reproductive technologies is likely to increase demand. For example, as per the PRB’s 2019 Family Planning Data Sheet, less than 15% of married women of reproductive age in the Democratic Republic of Congo use modern human reproduction technologies.
Global Human Reproductive Technologies Market: Key Developments
Key players in the market focus on approving and introducing new products to enlarge their product portfolio. For example, Evofem Biosciences, Inc., which received USFDA approval in May 2020, used Phexxi (potassium bitartrate, citric acid and lactic acid) for vaginal gel to prevent contraception in pregnant women using contraceptives.
Key players in the market focus on adopting collaboration strategies to enlarge their product portfolio. For example, Daré Bioscience, Inc., the developer of women’s healthcare, Health Decisions, Inc., partnered in May 2020 with a full-service contract research institute (CRO) specialized in women’s healthcare medical research and diagnostic development, which specifically targets health decisions. Provide CRO services in the US to support the research and development of the Daré’s pipeline of gynecological diseases, fertility and contraceptive products.
Global Human Reproductive Technologies Market: Segmentation
On the basis of Technologies, the Global Human Reproductive Technologies Market is segmented into:
- Infertility Drugs
- Contraceptive Drugs and Devices
On the basis of Region, the Global Human Reproductive Technologies Market is segmented into:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East
- Africa
Global Human Reproductive Technologies Market: Competitive Landscape
Key players performing in the global human reproductive technologies are Merck Serono, Daré Bioscience Inc., Johnson & Johnson, Ferring Pharmaceuticals, Cook Medical Inc., Pantarhei Bioscience B.V., Mayer Laboratories Inc., BioSante Pharmaceuticals Inc., Agile Therapeutics Inc., Pfizer Inc., Allergan, Church & Dwight Co. Inc., Bayer HealthCare AG, Merck & Co, Cryos USA, Mankind Pharma, HRA Pharma, SA, Aurobindo Pharma Limited, Sandoz International GmbH, Gavis Pharmaceuticals (Lupin Limited), Uniprix, Perrigo Company plc, Sun Pharmaceutical Industries Ltd., Actavis Generics (Teva Pharmaceutical Industries Ltd.), Evofem Biosciences Inc., and Abbott Laboratories.
Buy This Report With USD 2000 Flat OFF – https://www.coherentmarketinsights.com/promo/buynow/3921
Table of Content
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Global Human Reproductive Technologies Market Size Analysis from 2021 to 2027
11.6 COVID-19 Outbreak: Human Reproductive Technologies Industry Impact
Chapter 2 Global Human Reproductive Technologies Competition by Types, Applications, and Top Regions and Countries
2.1 Global Human Reproductive Technologies (Volume and Value) by Type
2.3 Global Human Reproductive Technologies (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Global Human Reproductive Technologies Sales, Consumption, Export, Import by Regions (2016-2021)
Chapter 5 North America Human Reproductive Technologies Market Analysis
Chapter 6 East Asia Human Reproductive Technologies Market Analysis
Chapter 7 Europe Human Reproductive Technologies Market Analysis
Chapter 8 South Asia Human Reproductive Technologies Market Analysis
Chapter 9 Southeast Asia Human Reproductive Technologies Market Analysis
Chapter 10 Middle East Human Reproductive Technologies Market Analysis
Chapter 11 Africa Human Reproductive Technologies Market Analysis
Chapter 12 Oceania Human Reproductive Technologies Market Analysis
Chapter 13 South America Human Reproductive Technologies Market Analysis
Chapter 14 Company Profiles and Key Figures in Human Reproductive Technologies Business
Chapter 15 Global Human Reproductive Technologies Market Forecast (2021-2027)
Chapter 16 Conclusions
Research Methodology
Continued….
Get PDF Brochure with Latest Insights @ https://www.coherentmarketinsights.com/insight/request-pdf/3921
About Us:
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837